Sertraline

CAS 79617-96-2 6 current records 3 historicalSmall Molecule

Who holds supplier records for Sertraline? 6 organisations hold a current record for Sertraline: an active US FDA Type II Drug Master File. A further 3 organisations have only historical (inactive) DMF filings. Recorded organisation countries for current records: India (6).

Most records are filed under another form of this substance: Sertraline Hydrochloride (19 current sources). A DMF or CEP is listed under the form it names.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Sertraline: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/sertraline

Reading the evidence

  • 6 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    6 of the 6 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 3 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (6)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Sertraline. Country is the organisation's recorded country, not necessarily the manufacturing site.

  • APITORIA PHARMA PRIVATE LTD
    Active DMF 22652 · latest filing Mar 2009
    India Company GMP cert on record
  • Exemed Pharmaceuticals
    Active DMF 40690 · latest filing Oct 2024
    India Company GMP cert on record
  • LEE PHARMA LTD
    Active DMF 37733 · latest filing Apr 2023
    India Company GMP cert on record
  • R L Fine Chem Pvt. Ltd.
    Active DMF 40764 · latest filing Oct 2024
    India
  • R.L.FINE CHEM PRIVATE LIMITED
    Active DMF 40528 · latest filing Sept 2024
    India
  • WANBURY LTD
    Active DMF 19931 · latest filing Oct 2006
    India
Need Sertraline sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Historical records (3)

Organisations whose Type II DMFs for Sertraline are no longer active. These show a past filing, not current supply.

Show all 3 historical records

US product patents and exclusivity

The FDA Orange Book lists patents and exclusivities for specific approved products (59 listed products contain Sertraline). The latest listed exclusivity ended 18 Jan 2026. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Sertraline is a selective serotonin reuptake inhibitor (SSRI) used primarily to treat major depressive disorder, anxiety and certain types of phobia. It functions by increasing the amount of serotonin, a natural substance in the brain that helps maintain mental balance.

Chemical identity

IUPAC name
(1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-amine
Canonical SMILES
CN[C@H]1CC[C@H](C2=CC=CC=C12)C3=CC(=C(C=C3)Cl)Cl
InChIKey
VGKDLMBJGBXTGI-KRWDZBQOSA-N

Therapeutic areas

DepressionAnxietyObsessive-Compulsive Disorder

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Sertraline?

6 organisations hold an active US FDA Type II Drug Master File or a CEP for Sertraline: APITORIA PHARMA PRIVATE LTD (India), Exemed Pharmaceuticals (India), LEE PHARMA LTD (India), R L Fine Chem Pvt. Ltd. (India), R.L.FINE CHEM PRIVATE LIMITED (India) and WANBURY LTD (India). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Sertraline Drug Master Files are active?

APITORIA PHARMA PRIVATE LTD (DMF 22652), Exemed Pharmaceuticals (DMF 40690), LEE PHARMA LTD (DMF 37733), R L Fine Chem Pvt. Ltd. (DMF 40764), R.L.FINE CHEM PRIVATE LIMITED (DMF 40528) and WANBURY LTD (DMF 19931). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Sertraline records mean?

3 organisations have only inactive Type II DMFs for Sertraline. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

How do I qualify a Sertraline supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Sertraline?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.